Original language | English |
---|---|
Pages (from-to) | 1829-1839 |
Journal | Lancet |
Volume | 380 |
Issue number | 9856 |
DOIs | |
Publication status | Published - 24 Nov 2012 |
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
CARE-MS | Investigators, Raymond Hupperts
Research output: Contribution to journal › Article › Academic › peer-review
705
Citations
(Web of Science)